Cargando…
Population pharmacokinetics of nadroparin for thromboprophylaxis in COVID‐19 intensive care unit patients
AIMS: Nadroparin is administered to COVID‐19 intensive care unit (ICU) patients as thromboprophylaxis. Despite existing population pharmacokinetic (PK) models for nadroparin in literature, the population PK of nadroparin in COVID‐19 ICU patients is unknown. Moreover, optimal dosing regimens achievin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878197/ https://www.ncbi.nlm.nih.gov/pubmed/36495312 http://dx.doi.org/10.1111/bcp.15634 |